Insight Molecular Diagnostics I IMDX
Price alert —
Sign in to get a one-time email the moment IMDX crosses your price. Free accounts included.
Sign in / create a free accountInsight Molecular Diagnostics I is a healthcare company listed in the US.
IMDX last traded at $4.74, up 0.6% on the day; that's in the middle part of its 52-week range ($2.42–$7.51). Right now it's dipped below its recent average — a spot where watchers often look for signs the dip is stabilizing.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
above KC1 lower, -0.66 ATR from EMA21 — no notable pattern
- · RSI hook from oversold (42)
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
- · Aligned with weak downtrend
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
IMDX is a $155 million company.